3rd Quarter - Report

PERSONALIZED MEDICINE COALITION for PERSONALIZED MEDICINE COALITION

Firm
Client
Income
—
Expenses
$44,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Congressional Personalized Medicine Caucus Precision Medicine Answers for Kids Today Act and Medicaid Early Periodic Screening, Diagnostic and Treatment Benefit 21st Century Cures 2.0 Initiative Response to House Request for Information American Privacy Rights Act provisions related to personalized medicine Oversight of Laboratory Developed Tests H.R. 5539/S. 3131 Optimizing Research Progress Hope And New (ORPHAN) Cures Act H.R. 5547/S.476 Maintaining Investments in New Innovation (MINI) Act H.R. 7174 Ensuring Pathways to Innovative Cures (EPIC) Act H.R. 8267 Old Drugs, New Cures Act H.R. 2407 Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act CMS Implementation of Medicare Drug Price Negotiation Program/ Medicare Drug Price Negotiation Program: Draft Guidance, Implementation of Sections 1191 - 1198 of the Social Security Act for Initial Price Applicability Year 2027 and Manufacturer Effectuation of the Maximum Fair Price in 2026 and 2027 Medicare and Medicaid Programs: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; etc (CMS-1809P) Medicare and Medicaid Programs; CY 2025 Payment Policies under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; etc (CMS-1807-P) Agency for Healthcare Research and Qualitys (AHRQs) Review Protocol titled: Blood-based Tests for Multiple Cancer Screening: A Systematic Review Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies [Docket No. FDA-2021-D0789] Standardizing Laboratory Practices in Pharmacogenomics (STRIPE) Collaborative Community

LobbyistCovered position, as disclosed
CYNTHIA BENS Staff, Representative Paul E. Kanjorski
DAVID L DAVENPORT —

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Agency for Healthcare Research & Quality (AHRQ); Food & Drug Administration (FDA); SENATE

Bills named: H.R. 7174 (118th), S. 3131 (118th), H.R. 5547 (118th), H.R. 5539 (118th), H.R. 2407 (118th), S. 476 (118th), H.R. 8267 (118th)

Budget/Appropriations BUD

FY 2025 Food and Drug Administration Budget Priorities for CDER, CBER and CDRH FY 2025 National Institutes of Health Budget Priorities

LobbyistCovered position, as disclosed
CYNTHIA BENS Staff, Representative Paul E. Kanjorski

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.